Literature DB >> 15017109

Retinal antigens are recognized by antibodies present in sera of patients with multiple sclerosis.

Wojciech A Gorczyca1, Maria Ejma, Danuta Witkowska, Marta Misiuk-Hojło, Marianna Kuropatwa, Małgorzata Mulak, Stanisław Szymaniec.   

Abstract

Multiple sclerosis (MS) is frequently accompanied by visual symptoms including those related to retinal disorders. Since they may be a consequence of an autoimmune reaction, we examined whether sera of patients with diagnosed MS and changes in visual-evoked potentials contain antibodies against retinal antigens (retAgs). Immunoblot analysis revealed that MS sera recognized mainly a 46-kD antigen, a 41-kD antigen, retinal arrestin, to a smaller extent also 70-, 56-, 43-, and 36-kD proteins. Patients whose sera showed the highest reactivity with 41- and 46-kD antigens had deficiencies in visual acuity, visual fields, ophthalmoscopy, and electroretinograms. Our observation suggests that antibodies to these retAgs may play a role in the origin of ophthalmologic impairment in MS. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017109     DOI: 10.1159/000076892

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  10 in total

1.  Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies.

Authors:  Farzin Forooghian; Melanie Sproule; Carol Westall; Lynn Gordon; Guy Jirawuthiworavong; Kaori Shimazaki; Paul O'Connor
Journal:  Doc Ophthalmol       Date:  2006-09-14       Impact factor: 2.379

2.  [Intraocular inflammation in multiple sclerosis].

Authors:  N Stübiger; K Ruprecht; U Pleyer
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

3.  Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis.

Authors:  Farzin Forooghian; Roy K Cheung; W Clay Smith; Paul O'Connor; Hans-Michael Dosch
Journal:  J Clin Immunol       Date:  2007-04-10       Impact factor: 8.317

4.  Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects.

Authors:  Elisabeth Olbert; Walter Struhal
Journal:  Wien Med Wochenschr       Date:  2022-03-28

Review 5.  [Uveitis in multiple sclerosis : Overview and perspectives].

Authors:  A L Hildebrandt; F Mackensen
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

Review 6.  [The role of uveitis in demyelinating diseases of the central nervous system].

Authors:  A-M Beyer; B Rosche; U Pleyer; K P Wandinger
Journal:  Nervenarzt       Date:  2007-12       Impact factor: 1.214

7.  Enolase autoantibodies and retinal function in multiple sclerosis patients.

Authors:  Farzin Forooghian; Grazyna Adamus; Melanie Sproule; Carol Westall; Paul O'Connor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.535

Review 8.  The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis.

Authors:  Fiona Costello
Journal:  ISRN Neurol       Date:  2013-11-06

9.  Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis.

Authors:  Lucia Ziccardi; Lucilla Barbano; Laura Boffa; Maria Albanese; Carolina Gabri Nicoletti; Doriana Landi; Andrzej Grzybowski; Benedetto Falsini; Girolama Alessandra Marfia; Diego Centonze; Vincenzo Parisi
Journal:  J Clin Med       Date:  2020-11-22       Impact factor: 4.241

10.  Cancer-associated retinopathy in patients with breast carcinoma.

Authors:  Marta Misiuk-Hojło; Maria Ejma; Wojciech A Gorczyca; Stanisław Szymaniec; Danuta Witkowska; Wojciech Fortuna; Ryszard Miedzybrodzki; Jadwiga Rogozińska-Szczepka; Wiesława Bartnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.